Novel immunotherapy technology for prostate cancer – Drug Target Review
Drug Target Review |
Novel immunotherapy technology for prostate cancer
Drug Target Review Scientists have described a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific protein. Researchers at The Wistar Institute devised a novel … |
